Biotech | May 25, 2022
ENPICOM launches versatile display data analysis solution to accelerate antibody selection
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
Subscribe To Our Newsletter & Stay Updated
